Results 161 to 170 of about 2,666,075 (354)

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

La naturaleza del sujeto y el argumento de la unidad

open access: yesCrítica, 2019
En el presente trabajo examino diversas respuestas a la pregunta formulada por Descartes ¿Qué soy yo? Sugiero que, aunque la propuesta según la cual soy idéntico a mi organismo humano o a alguna parte del mismo (la tesis adoptada por los materialistas ...
Adrián Sampedro
doaj  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Semiotica per campagne di digital marketing. Alcune proposte operative

open access: yesOcula
This work is part of the extensive series of semiotic studies that, from the late 1980s to the present, have dialogued with the most diverse areas of marketing, up to the most recent digital marketing.
Giovanna Cosenza
doaj  

Normas para la protección y cuidado de personas ante la pandemia COVID-19 [PDF]

open access: diamond, 2020
Reynaldo Michel-Aceves   +6 more
openalex   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy